Cargando…
Development and In vivo Pharmacokinetic and Pharmacodynamic Evaluation of an Oral Innovative Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan Formulation for Enhanced Bioavailability
Background: Irbesartan (IR) is used in the treatment of hypertension, heart failure, and nephropathy in Type II diabetes. IR bioavailability is limited by poor solubility and presystemic metabolism. In our previous investigations, cyclodextrin (HPβCD) complexed solid lipid nanoparticles (SLNs) of IR...
Autores principales: | Dudhipala, Narendar, Ettireddy, Swetha, Youssef, Ahmed Adel Ali, Puchchakayala, Goverdhan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760361/ https://www.ncbi.nlm.nih.gov/pubmed/36593793 http://dx.doi.org/10.7150/ntno.78102 |
Ejemplares similares
-
Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan for Oral Applications: Design, Development, and In Vitro Characterization
por: Dudhipala, Narendar, et al.
Publicado: (2021) -
Neuroprotective Effect of Ropinirole Lipid Nanoparticles Enriched Hydrogel for Parkinson’s Disease: In Vitro, Ex Vivo, Pharmacokinetic and Pharmacodynamic Evaluation
por: Dudhipala, Narendar, et al.
Publicado: (2020) -
Dual Drug Loaded Lipid Nanocarrier Formulations for Topical Ocular Applications
por: Youssef, Ahmed Adel Ali, et al.
Publicado: (2022) -
Innovative Treatment Strategies to Accelerate Wound Healing: Trajectory and Recent Advancements
por: Kolimi, Praveen, et al.
Publicado: (2022) -
Ciprofloxacin Loaded Nanostructured Lipid Carriers Incorporated into In-Situ Gels to Improve Management of Bacterial Endophthalmitis
por: Youssef, Ahmed, et al.
Publicado: (2020)